- US-listed companies
- Novo Integrated Sciences, Inc.
- Financials
- Cost of revenue
Novo Integrated Sciences, Inc. (NVOS)
Market cap
$76.95K
P/E ratio
| Period End | Cost of revenue (Million USD) | YoY (%) |
|---|---|---|
| Aug 31, 2024 | 8 | -0.89% |
| Aug 31, 2023 | 8 | +9.81% |
| Aug 31, 2022 | 7 | +26.57% |
| Aug 31, 2021 | 5 | +14.16% |
| Aug 31, 2020 | 5 | -18.64% |
| Aug 31, 2019 | 6 | +7.88% |
| Aug 31, 2018 | 5 | +9.74% |
| Aug 31, 2017 | 5 |